0001104659-23-037023.txt : 20230327 0001104659-23-037023.hdr.sgml : 20230327 20230327131220 ACCESSION NUMBER: 0001104659-23-037023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230323 FILED AS OF DATE: 20230327 DATE AS OF CHANGE: 20230327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Souza Marcio CENTRAL INDEX KEY: 0001707657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39620 FILM NUMBER: 23763425 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Praxis Precision Medicines, Inc. CENTRAL INDEX KEY: 0001689548 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET, 30TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-300-8460 MAIL ADDRESS: STREET 1: 99 HIGH STREET, 30TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 tm2310645-3_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-03-23 0 0001689548 Praxis Precision Medicines, Inc. PRAX 0001707657 Souza Marcio C/O PRAXIS PRECISION MEDICINES, INC. 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-03-23 4 P 0 35000 0.8617 A 226299 D Common Stock 2023-03-23 4 P 0 35001.75 0.863 A 35001.75 I Held by spouse The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.863, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8572 to $0.8676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. /s/ Alex Nemiroff, as Attorney-in-Fact 2023-03-27